BAKER DOUGLAS P — Insider transactions, CFO at OptimizeRx Corp / NANO PROPRIETARY INC | InsiderLens

FrançaisSign in Try free 14d

BAKER DOUGLAS P

USReporting entityCFO

Transactions

112

Issuers

2

Buys / Sells

10/34

Last tx

05 Oct 2021

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
NANO PROPRIETARY INC	1,249,100	reported	30 Apr 2012	tx 19+1,246,600−32,000
OptimizeRx Corp	34,796	reported	05 Oct 2021	tx 93+823,784−414,324

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
05 Oct 2021	EXERCISE	OptimizeRx Corp	10,000	7.51 USD
05 Oct 2021	SALE	OptimizeRx Corp	4,000	84.22 USD
05 Oct 2021	SALE	OptimizeRx Corp	10,000	82.35 USD
05 Oct 2021	EXERCISE	OptimizeRx Corp	10,000	7.51 USD	deriv
28 Sept 2021	SALE	OptimizeRx Corp	2,000	74.66 USD
21 Sept 2021	SALE	OptimizeRx Corp	4,000	70.59 USD
14 Sept 2021	SALE	OptimizeRx Corp	3,768	65.57 USD
07 Sept 2021	SALE	OptimizeRx Corp	2,232	70.53 USD
08 Sept 2021	EXERCISE	OptimizeRx Corp	10,000	7.51 USD
08 Sept 2021	SALE	OptimizeRx Corp	10,000	67.25 USD
08 Sept 2021	EXERCISE	OptimizeRx Corp	10,000	7.51 USD	deriv
31 Aug 2021	SALE	OptimizeRx Corp	4,000	66.62 USD
20 Aug 2021	SALE	OptimizeRx Corp	5,000	58.45 USD
24 Aug 2021	SALE	OptimizeRx Corp	4,000	61.50 USD
13 Aug 2021	SALE	OptimizeRx Corp	5,000	63.27 USD
17 Aug 2021	SALE	OptimizeRx Corp	4,000	58.46 USD
10 Aug 2021	SALE	OptimizeRx Corp	2,000	64.50 USD
09 Aug 2021	EXERCISE	OptimizeRx Corp	10,000	7.51 USD
09 Aug 2021	SALE	OptimizeRx Corp	10,000	64.31 USD
09 Aug 2021	EXERCISE	OptimizeRx Corp	10,000	7.51 USD	deriv
03 Aug 2021	SALE	OptimizeRx Corp	2,000	54.93 USD
27 Jul 2021	SALE	OptimizeRx Corp	3,000	52.58 USD
20 Jul 2021	SALE	OptimizeRx Corp	3,000	50.90 USD
08 Jul 2021	EXERCISE	OptimizeRx Corp	13,435	2.46 USD
08 Jul 2021	SALE	OptimizeRx Corp	13,435	56.05 USD